Cargando…
Can Dexmedetomidine Prevent the Unwanted Hemolytic Events in the Glucose-6-Phosphate Dehydrogenase-deficient Person Undergoing Cardiac Surgery?
Autor principal: | Yousefi Moghadam, Manijeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319032/ https://www.ncbi.nlm.nih.gov/pubmed/30662884 http://dx.doi.org/10.4103/abr.abr_195_18 |
Ejemplares similares
-
Hemolytic Anemia due to Glucose 6 Phosphate Dehydrogenase Deficiency Triggered by Type 1 Diabetes Mellitus
por: Orman, Burçe, et al.
Publicado: (2023) -
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report
por: Wu, Shuxie, et al.
Publicado: (2018) -
Acquired Glucose-6-Phosphate Dehydrogenase Deficiency
por: Pes, Giovanni Mario, et al.
Publicado: (2022) -
Anaesthetic management in patients with glucose-6-phosphate dehydrogenase deficiency undergoing neurosurgical procedures
por: Valiaveedan, Sebastian, et al.
Publicado: (2011) -
HEMOLYTIC ANEMIA AND METHEMOGLOBINEMIA DUE TO HYDROXYCHLOROQUINE USE FOR COVID-19 TREATMENT IN A GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT PATIENT
por: Lim, Steven, et al.
Publicado: (2020)